**Core Concept**
Multiple myeloma is a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow, leading to various systemic complications. One of the hallmark features of multiple myeloma is bone destruction, which can result in the release of minerals from the bone matrix into the bloodstream, causing electrolyte imbalances.

**Why the Correct Answer is Right**
Hypercalcemia is a common metabolic abnormality seen in multiple myeloma due to the breakdown of bone tissue. The malignant plasma cells in the bone marrow secrete various factors, including parathyroid hormone-related protein (PTHrP), which stimulates the osteoclasts to resorb bone, releasing calcium into the bloodstream. This process is often referred to as "bone destruction" or "bone lysis." The resulting hypercalcemia can lead to symptoms such as weakness, fatigue, confusion, and even cardiac arrhythmias.

**Why Each Wrong Option is Incorrect**
**Option A:** Hyponatremia is not typically associated with multiple myeloma. In fact, hypernatremia (elevated sodium levels) can occur due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH), which is sometimes seen in cancer patients.

**Option B:** Hypokalemia (low potassium levels) is not a characteristic feature of multiple myeloma. While electrolyte imbalances can occur, hypokalemia is more commonly associated with other conditions such as gastrointestinal losses or renal impairment.

**Option D:** Hyperphosphatemia (elevated phosphate levels) can occur in multiple myeloma, but it is not as common as hypercalcemia. The increased phosphate levels can be due to the release of phosphate from the bone matrix or impaired renal excretion.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that hypercalcemia in multiple myeloma is often accompanied by other laboratory abnormalities, including anemia, thrombocytopenia, and elevated levels of creatinine. A high index of suspicion for hypercalcemia is crucial in the diagnosis and management of multiple myeloma.

**Correct Answer Line**
✓ Correct Answer: C. Hypercalcemia